News Sentiment

MASS sentiment intelligence

908 Devices Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 51 Balanced news tone 64 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 8.10 Week of 10 Jul 2026
Weighted tone 51/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

77/100 classification confidence.

Company focus 64

directly relevant articles

Source quality 5

high-authority source matches

Trend context Trend active

-6.8% over one week, -2.1% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Reflecting On Medical Devices & Supplies - Specialty Stocks’ Q1 Earnings: Integer Holdings (NYSE:ITGR)

Market Reaction

Price moving ahead of tone

58/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 77/100 classification
One-week reaction -6.8% Price reacting lower
Trend fit Trend active -2.1% over four weeks
Fair value 38.0% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 10
Neutral 43
Negative 11

Relevance

Why the article matched

Direct first
Direct company coverage 64
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 17
Stock Titan 9
Investing.com 6
Investing.com Nigeria 4
Quartr 3
TradingView 2
StockStory 2
Zacks 2

Event Lens

What the news is about

Classified themes
Market update 32
Earnings 23
Deals and strategy 6
Analyst action 2
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 64
Quartr Direct company coverage

908 Devices (MASS) Stifel 2025 Healthcare Conference Summary

908 Devices (MASS) presented a summary of its business transformation and future plans at the Stifel 2025 Healthcare Conference. Key points included the acquisition of RedWave and divestment of its PAT business, expanding its handheld product portfolio and strengthening its balan

Tone
Positive 70/100
Event
Deals and strategy
Published
09 Jul 2026 06:40
Source
Quartr
Minichart Direct company coverage

908 Devices Inc. Files Form 8-K: Company Information, NASDAQ Listing, and Key Entity Details for July 2026

908 Devices Inc. has issued 3,213,583 shares of common stock to fulfill its earnout obligations related to the acquisition of RedWave Technology. This issuance was triggered by achieving a revenue milestone of $37 million from RedWave products and services within a two-year perio

Tone
Positive 63/100
Event
Deals and strategy
Published
09 Jul 2026 00:09
Source
Minichart
TradingView Direct company coverage

908 Devices issues 3.21M shares to satisfy RedWave earnout after revenue hurdle met

908 Devices (MASS) has issued 3,213,583 shares to complete the earnout consideration for its RedWave acquisition. This issuance confirms that RedWave met the revenue threshold of at least $37 million in aggregate revenue from specific products and services between May 1, 2024, an

Tone
Positive 69/100
Event
Deals and strategy
Published
08 Jul 2026 20:09
Source
TradingView
Stock Titan Direct company coverage

908 Devices (MASS) completes RedWave earnout with 3.2M-share stock payment

908 Devices Inc. (MASS) has completed its earnout obligations for the acquisition of RedWave Technology by issuing 3,213,583 shares of common stock. This payment satisfies the terms of the April 29, 2024 Equity Purchase Agreement, which stipulated an earnout based on RedWave's re

Tone
Neutral 50/100
Event
Deals and strategy
Published
08 Jul 2026 20:09
Source
Stock Titan
Quartr Direct company coverage

908 Devices (MASS) Leerink Global Healthcare Conference 2026 Summary

908 Devices presented at the Leerink Global Healthcare Conference 2026, highlighting market drivers such as the illicit drug crisis and global unrest, which are increasing demand for their solutions. The company reported 21% revenue growth in Q4, exceeding guidance, and anticipat

Tone
Positive 73/100
Event
Earnings
Published
08 Jul 2026 18:10
Source
Quartr
Quartr Direct company coverage

908 Devices (MASS) Leerink’s Global Healthcare Conference 2025 Summary

908 Devices (MASS) announced a strategic transformation at Leerink’s Global Healthcare Conference 2025, divesting its biopharma desktop portfolio for $70 million to focus on high-growth handheld markets. The company expects revenue from continuing operations to be $53–$55 million

Tone
Positive 70/100
Event
Earnings
Published
08 Jul 2026 18:10
Source
Quartr
Investing.com Nigeria Direct company coverage

Form 4 908 Devices Inc For: 7 July By Investing.com

This article from Investing.com announces a Form 4 filing for 908 Devices Inc. on July 7th. It is a very brief piece of content without further details.

Tone
Neutral 50/100
Event
Market update
Published
08 Jul 2026 05:46
Source
Investing.com Nigeria
Stock Titan Direct company coverage

908 Devices (MASS) CEO Knopp logs small 222-share sale under Rule 10b5-1 plan

908 Devices Inc. CEO Kevin J. Knopp reported an open-market sale of 222 shares of common stock at a weighted average price of $9.07 per share, executed under a Rule 10b5-1 trading plan adopted on May 20, 2025. After this transaction, Knopp directly holds 732,603 shares and indire

Tone
Neutral 50/100
Event
Market update
Published
07 Jul 2026 20:41
Source
Stock Titan
Stock Titan Direct company coverage

Director at 908 Devices (MASS) sells 2,200 shares under 10b5-1 plan

Christopher D. Brown, a director at 908 Devices (MASS), sold 2,200 shares of common stock on July 2, 2026, at a weighted average price of $9.02 per share. This transaction was conducted under a pre-arranged Rule 10b5-1 trading plan adopted in November 2025. Following the sale, Br

Tone
Negative 40/100
Event
Market update
Published
07 Jul 2026 20:41
Source
Stock Titan
Investing.com Direct company coverage

908 Devices director Christopher Brown sells $19,844 in stock

Christopher D. Brown, a director at 908 Devices Inc. (NASDAQ:MASS), sold 2,200 shares of company stock for a total of $19,844 on July 2, 2026, under a pre-arranged trading plan. Following the sale, Brown still retains 843,359 shares. This transaction occurred despite the company'

Tone
Negative 38/100
Event
Market update
Published
07 Jul 2026 20:41
Source
Investing.com
Medical Product Outsourcing Direct company coverage

Kola Otitoju Named Chief Business & Strategy Officer at 908 Devices

908 Devices Inc. has appointed Kola Otitoju as its new chief business and strategy officer, a newly created role. He will be responsible for product and corporate strategy, business development, M&A, and partnership initiatives as the company expands its market presence. Otitoju

Tone
Neutral 50/100
Event
Deals and strategy
Published
07 Jul 2026 13:40
Source
Medical Product Outsourcing
Stock Titan Direct company coverage

908 Devices (MASS) director sells 20,000 shares under 10b5-1 plan

Christopher D. Brown, a director at 908 Devices Inc. (MASS), sold 20,000 shares of common stock at an average price of $8.84 per share. This transaction, totaling $176,800, was executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 24, 2025. Following the sale

Tone
Negative 39/100
Event
Market update
Published
02 Jul 2026 20:39
Source
Stock Titan
Investing.com Nigeria Direct company coverage

Form 4 908 Devices Inc For: 30 June By Investing.com

This article reports on the filing of Form 4 by 908 Devices Inc. for the period ending June 30, 2026. Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) whenever there is a change in the beneficial ownership of a company's securities by

Tone
Neutral 50/100
Event
Market update
Published
01 Jul 2026 16:10
Source
Investing.com Nigeria
Investing.com Direct company coverage

908 Devices CEO Kevin Knopp sells $25,433 in company stock

Kevin J. Knopp, CEO of 908 Devices Inc. (NASDAQ:MASS), sold 2,798 shares of company stock for $25,433 on June 26, 2026, at an average price of $9.09 per share. This transaction was part of a Rule 10b5-1 trading plan established in May 2025. Following the sale, Knopp directly hold

Tone
Neutral 50/100
Event
Market update
Published
01 Jul 2026 02:39
Source
Investing.com
Stock Titan Direct company coverage

908 Devices (MASS) CEO sells 2,798 shares under Rule 10b5-1 plan

Kevin J. Knopp, President and CEO of 908 Devices Inc. (MASS), sold 2,798 shares of common stock at a weighted average price of $9.09 per share under a pre-arranged Rule 10b5-1 trading plan. Following the transaction, Knopp directly holds 732,825 shares, with an additional 541,223

Tone
Negative 37/100
Event
Market update
Published
01 Jul 2026 02:39
Source
Stock Titan
Investing.com South Africa Direct company coverage

908 Devices CEO Kevin Knopp sells $25,433 in company stock By Investing.com

Kevin J. Knopp, CEO of 908 Devices Inc., sold 2,798 shares of the company's common stock for $25,433 on June 26, 2026, as part of a Rule 10b5-1 trading plan. Despite recent stock momentum and revenue growth in Q1 2026, the company remains unprofitable with shares appearing slight

Tone
Negative 39/100
Event
Earnings
Published
30 Jun 2026 22:09
Source
Investing.com South Africa
www.marketscreener.com Direct company coverage

908 Devices Inc.(NasdaqGM:MASS) dropped from Russell Microcap Growth Benchmark Index

908 Devices Inc. (NasdaqGM:MASS) has been removed from the Russell Microcap Growth Benchmark Index. The article also lists recent news regarding the company, including its Q1 2026 earnings call, an agreement to acquire NIRLAB Sarl for $23 million, and its Q4 2025 earnings results

Tone
Negative 30/100
Event
Earnings
Published
29 Jun 2026 12:11
Source
www.marketscreener.com
TradingView Direct company coverage

908 Devices Inc. Actuals & Estimates (NASDAQ:MASS)

This article provides an overview of 908 Devices Inc. (NASDAQ: MASS) stock performance, financial actuals, and analyst estimates. It highlights key financial figures such as current price, market capitalization, earnings, and revenue, and includes analyst forecasts for future pri

Tone
Positive 66/100
Event
Earnings
Published
26 Jun 2026 14:39
Source
TradingView
Stock Titan Direct company coverage

Director at 908 Devices (NASDAQ: MASS) converts 6,486 RSUs into common stock

908 Devices (NASDAQ: MASS) director Michele M. Leonhart converted 6,486 restricted stock units (RSUs) into common stock, acquiring 6,486 shares at $0.00 each as part of her equity compensation. Following this transaction, Leonhart directly holds 27,054 shares of common stock. The

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 00:39
Source
Stock Titan
Investing.com Nigeria Direct company coverage

Form 4 908 Devices Inc For: 25 June By Investing.com

This article from Investing.com reports on a Form 4 filing for 908 Devices Inc. on June 25, 2026. The brief piece includes the stock symbol MASS, which experienced a -2.23% change, alongside various market data and other Investing.com articles.

Tone
Neutral 50/100
Event
Market update
Published
25 Jun 2026 21:22
Source
Investing.com Nigeria
Stock Titan Direct company coverage

908 Devices (MASS) CEO sells 60,345 shares under Rule 10b5-1 trading plan

Kevin J. Knopp, President and CEO of 908 Devices (MASS), reported selling 60,345 shares of common stock in open-market transactions over three days in June 2026. These sales, totaling approximately $550,624, were executed under a pre-scheduled Rule 10b5-1 trading plan adopted on

Tone
Negative 42/100
Event
Market update
Published
25 Jun 2026 21:11
Source
Stock Titan
Stock Titan Direct company coverage

908 Devices (MASS) director sells 9,900 shares under 10b5-1 plan

Christopher D. Brown, a director at 908 Devices Inc. (MASS), sold 9,900 shares of common stock at a weighted average price of $9.04 per share. This transaction was conducted under a predetermined Rule 10b5-1 trading plan adopted on November 24, 2025. Following the sale, Brown sti

Tone
Negative 41/100
Event
Market update
Published
25 Jun 2026 21:11
Source
Stock Titan
Investing.com Nigeria Direct company coverage

908 Devices director Brown sells $89,495 in shares By Investing.com

Christopher D. Brown, a director at 908 Devices Inc. (NASDAQ:MASS), sold 9,900 shares of common stock on June 23, 2026, totaling $89,495. This sale was conducted under a Rule 10b5-1 trading plan and occurred while the stock was trading near its 52-week high, following a significa

Tone
Negative 40/100
Event
Market update
Published
25 Jun 2026 13:40
Source
Investing.com Nigeria
Stock Titan Direct company coverage

AWM Investment (MASS) funds log small open-market sales but keep large stake

AWM Investment Company, Inc., a major owner of 908 Devices Inc. (MASS), reported open-market sales of 7,718 shares of the company's common stock on June 22 and 23 at around $9 per share. Despite these sales, AWM-advised funds still indirectly hold a substantial stake of 4,879,773

Tone
Neutral 50/100
Event
Deals and strategy
Published
24 Jun 2026 20:41
Source
Stock Titan
Investing.com Direct company coverage

Form 144 908 Devices Inc For: 23 June

This article announces a Form 144 filing for 908 Devices Inc. on June 23. It also includes standard disclaimers about the high risks involved in trading financial instruments and cryptocurrencies, emphasizing that data on Investing.com is not always real-time or accurate. The con

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 22:40
Source
Investing.com